Literature DB >> 11205444

Congenital CMV-infection and hearing loss.

N Lagasse1, I Dhooge, P Govaert.   

Abstract

CMV (cytomegalovirus) is one of the Herpesviridae, known for their potential for latency and reactivation. The sequelae of fetal infection are diverse: chronic stage of early fetal infection with brain anomalies, symptomatic late fetal infection with hepatitis and thrombocytopenia and asymptomatic infection. With any of these clinical phenotypes, permanent hearing loss is possible. CMV-infection is the only relevant viral cause of perinatal hearing loss because rubella, measles and mumps have become rare due to vaccination. Recent studies have suggested beneficial effects on outcome of i.v. ganciclovir treatment in symptomatic cases. We have recently taken the challenge of treating asymptomatic newborns on the basis of active sonographic brain lesions in order to prevent labyrinth destruction. We would also like to stress the importance of suspecting children with congenital hearing loss, or hearing loss that develops in the first year of life, of having an asymptomatic congenital CMV-infection. Follow up in the first years of life is necessary in these children because further progression of hearing loss is possible.

Entities:  

Mesh:

Year:  2000        PMID: 11205444

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Belg        ISSN: 0001-6497


  5 in total

Review 1.  Universal newborn hearing screening in 2010.

Authors:  Daniel Choo; Jareen Meinzen-Derr
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2010-10       Impact factor: 2.064

2.  Human cytomegalovirus (HCMV) and hearing impairment: infection of fibroblast cells with HCMV induces chromosome breaks at 1q23.3, between loci DFNA7 and DFNA49 -- both involved in dominantly inherited, sensorineural, hearing impairment.

Authors:  Mona Nystad; Toril Fagerheim; Vigdis Brox; Elizabeth A Fortunato; Øivind Nilssen
Journal:  Mutat Res       Date:  2007-07-25       Impact factor: 2.433

3.  Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma.

Authors:  Duane A Mitchell; Weihua Xie; Robert Schmittling; Chris Learn; Allan Friedman; Roger E McLendon; John H Sampson
Journal:  Neuro Oncol       Date:  2007-10-19       Impact factor: 12.300

Review 4.  Congenital cytomegalovirus infection.

Authors:  Alexander K C Leung; Reginald S Sauve; H Dele Davies
Journal:  J Natl Med Assoc       Date:  2003-03       Impact factor: 1.798

5.  Trends in hospitalizations for diagnosed congenital cytomegalovirus in infants and children in Australia.

Authors:  Holly Seale; Robert Booy; C Raina MacIntyre
Journal:  BMC Pediatr       Date:  2009-01-26       Impact factor: 2.125

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.